<p><h1>Bio-absorbable Stents Market Research Report Provides Critical Insights that can help Shape Business Development and Investment Strategies</h1></p><p><strong>Bio-absorbable Stents Market Analysis and Latest Trends</strong></p>
<p><p>Bio-absorbable stents, also known as bioresorbable scaffolds (BRS), are medical devices that are used to treat coronary artery disease (CAD). These stents are made from biodegradable materials that gradually dissolve and disappear from the body over time, leaving the artery free of any foreign material. </p><p>Bio-absorbable stents offer several advantages over traditional metal stents, such as reducing the risk of long-term complications like stent thrombosis and restenosis. They also allow the artery to heal and regain its natural function. The bio-absorbable stents market is primarily driven by the increasing prevalence of CAD and the rising demand for minimally invasive procedures. </p><p>The market analysis of the bio-absorbable stents market suggests significant growth during the forecast period. The market is expected to grow at a CAGR of 11.8% during this period. Several factors contribute to this growth, such as technological advancements in stent design and materials, increasing research and development activities, and the growing adoption of bio-absorbable stents in emerging economies. </p><p>Moreover, factors like the development of bio-absorbable stents with improved mechanical properties and drug-eluting capabilities further drive market growth. Additionally, the growing focus of key players in research and development activities to enhance the safety and efficacy of bio-absorbable stents is expected to bolster market growth. </p><p>However, factors like the high cost of bio-absorbable stents and the lack of long-term clinical trial data may hamper market growth to some extent. Nevertheless, the bio-absorbable stents market is expected to witness substantial growth in the coming years, with the increasing adoption of these devices as an alternative to traditional metal stents.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp; <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1695091">https://www.reliableresearchreports.com/enquiry/request-sample/1695091</a></strong></p>
<p>&nbsp;</p>
<p><strong>Bio-absorbable Stents Major Market Players</strong></p>
<p><p>The bio-absorbable stents market is highly competitive, with several key players dominating the industry. Some of the major players in the market include Boston Scientific, Abbott Laboratories, Elixir Medical, Kyoto Medical Planning, and F. Hoffmann-La Roche. </p><p>Boston Scientific is a leading global medical device company that focuses on the development of innovative solutions for various medical conditions. The company was founded in 1979 and has since become a pioneer in the bio-absorbable stents market. Boston Scientific offers a range of bio-absorbable stents, including the Synergy and Promus Premier stents. The company has experienced consistent growth in the market due to continuous product development and strategic acquisitions. The market size for Boston Scientific's bio-absorbable stents is estimated to be around $500 million.</p><p>Abbott Laboratories is another prominent player in the bio-absorbable stents market. The company has a long history in the healthcare industry, dating back to 1888. Abbott has been at the forefront of bio-absorbable stent development with its product, Absorb. However, in 2017, the company halted global sales of Absorb due to concerns over potential safety issues. Despite this setback, Abbott Laboratories remains a major player in the market and is actively involved in ongoing research and development efforts.</p><p>Elixir Medical Corporation is a California-based medical device company that specializes in the development of advanced bio-absorbable stents. The company was founded in 2007 and has rapidly gained recognition for its innovative stent technology. Elixir Medical's bio-absorbable stents, such as DESolve and DESolve NX, offer unique features and benefits, leading to steady market growth for the company. The sales revenue of Elixir Medical is estimated to be around $50 million.</p><p>Kyoto Medical Planning is a Japanese medical device company that focuses on the development and commercialization of bio-absorbable stents. The company has been actively involved in clinical trials to assess the efficacy and safety of its stents. Kyoto Medical Planning has witnessed a significant increase in market share, primarily due to its strong presence in the Asia-Pacific region. The exact sales revenue of Kyoto Medical Planning is not publicly available.</p><p>F. Hoffmann-La Roche, more commonly known as Roche, is a multinational pharmaceutical and diagnostic company. Although not primarily focused on bio-absorbable stents, Roche has made substantial investments in developing innovative medical devices. The company's presence in the bio-absorbable stents market is limited, and the exact market size and sales revenue are not available.</p><p>Overall, the bio-absorbable stents market is highly dynamic and competitive, with several key players driving innovation and growth. Boston Scientific and Abbott Laboratories have a significant market presence, while Elixir Medical and Kyoto Medical Planning have made notable advancements in the field. Despite the challenges faced by the industry, the market is expected to witness continued growth in the coming years as technology advances and more clinical evidence becomes available.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Bio-absorbable Stents Manufacturers?</strong></p>
<p><p>The bio-absorbable stents market has been witnessing significant growth due to the rising prevalence of cardiovascular diseases and the increasing demand for minimally invasive procedures. The market is driven by advancements in stent technology, such as biodegradable materials and drug-eluting coatings, which promote efficient healing and reduce the risk of restenosis. Moreover, the growing geriatric population and the increasing adoption of bio-absorbable stents by healthcare providers are further contributing to market growth. However, the high cost of these stents and the availability of alternative treatment options pose challenges to market expansion. Nevertheless, with ongoing research and development activities, the bio-absorbable stents market is expected to witness promising growth in the coming years.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report: <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1695091">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1695091</a></strong></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Bio-absorbable Stents Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Metallic Stents</li><li>Polymeric Stents</li></ul></p>
<p><p>Bio-absorbable stents are a type of medical device used to treat narrow or blocked blood vessels, particularly in the heart. Metallic stents are made of materials like stainless steel or cobalt-chromium alloy, providing structural support to the artery. Polymeric stents, on the other hand, are composed of biodegradable materials that gradually dissolve over time, allowing the artery to heal and regain its natural function. Both types have their advantages and considerations, and the choice depends on individual patient factors and physician preferences.</p></p>
<p><strong>Purchase this Report:&nbsp;<a href="https://www.reliableresearchreports.com/purchase/1695091">https://www.reliableresearchreports.com/purchase/1695091</a></strong></p>
<p>&nbsp;</p>
<p><strong>The Bio-absorbable Stents Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>PAD</li><li>CAD</li></ul></p>
<p><p>The bio-absorbable stents market has significant applications in the treatment of peripheral artery disease (PAD) and coronary artery disease (CAD). In PAD, these stents are used to restore blood flow in arteries of arms and legs affected by plaque buildup, reducing the risk of amputation. In CAD, the stents are utilized to open up narrowed or blocked coronary arteries, improving blood flow to the heart and reducing the risk of heart attack. These bio-absorbable stents gradually dissolve over time, eliminating the need for long-term implantation and reducing complications associated with traditional metal stents.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Bio-absorbable Stents Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The bio-absorbable stents market is projected to witness significant growth across North America (NA), Asia-Pacific (APAC), Europe, the United States (USA), and China. NA is expected to dominate the market due to the increasing prevalence of cardiovascular diseases and a well-established healthcare infrastructure. APAC is also anticipated to experience substantial growth owing to the rising geriatric population and improving healthcare facilities in emerging economies. Europe is expected to hold a significant market share percentage due to the increasing adoption of technologically advanced medical devices. However, detailed market share valuations are proprietary data and not publicly available.</p></p>
<p><strong>Purchase this Report: <a href="https://www.reliableresearchreports.com/purchase/1695091">https://www.reliableresearchreports.com/purchase/1695091</a></strong></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;<a href="https://www.reliableresearchreports.com/enquiry/request-sample/1695091">https://www.reliableresearchreports.com/enquiry/request-sample/1695091</a></strong></p>
<p><strong></strong></p>
<p><p><a href="https://www.linkedin.com/pulse/brain-edema-treatment-market-size-2023-2030-global-industrial-a6sge/">Brain Edema Treatment Market</a></p><p><a href="https://medium.com/@sink.pay.sand/commercial-vehicle-fuel-tank-market-outlook-industry-overview-and-forecast-2023-to-2030-fbc5ca5715eb">Commercial Vehicle Fuel Tank Market</a></p><p><a href="https://www.linkedin.com/pulse/follicular-lymphoma-treatment-market-size-share-amp-trends-oqfre/">Follicular Lymphoma Treatment Market</a></p><p><a href="https://www.linkedin.com/pulse/acne-vulgaris-treatment-market-insights-players-forecast-yl76e/">Acne Vulgaris Treatment Market</a></p><p><a href="https://medium.com/@fire.belt.bug/coating-solvent-market-insight-market-trends-growth-forecasted-from-2023-to-2030-0e1e440a2c7c">Coating Solvent Market</a></p></p>